TARS Tarsus Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$73.00
· of 52w range
· above low
· to high
$53.8952w low
$91.5352w high
Market Cap (MRQ)
$3.16B
P/E (TTM)
-68.9
EPS (TTM)
$-1.06
Revenue (TTM)
$606M
your badges
52W Range
$54–$92
Analyst Rating
STRONG BUY
Price Target
$100
P/E
-68.9
ROE
-13.7%
Net Profit Margin
-7.7%
Your badge strip is empty — pin a metric anywhere on this page.
TARS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$73.00
Market Cap (MRQ)
$3.16B
P/E (TTM)
-68.9
EPS (TTM)
$-1.06
Revenue (TTM)
$606M
ROE (TTM)
-13.7%
Debt/Equity (MRQ)
0.2
52W Range
$54–$92
TARS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$451M2020-12-31 → 2025-12-31
EPS$-1.592020-12-31 → 2025-12-31
Free Cash Flow$-22M2020-12-31 → 2025-12-31
Net margin-7.7%2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | TARS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -68.95Y avg ≈-22.7 | ≈-22.7 | · | · | |
| P/S (TTM) | 5.25Y avg ≈16.5 | ≈16.5 | · | · | |
| P/B (MRQ) | 9.15Y avg ≈5.6 | ≈5.6 | 6.5 | Overvalued | |
| EV / EBITDA | -39.45Y avg ≈-16.6 | ≈-16.6 | · | · | |
| Price / FCF (TTM) | 56.45Y avg ≈-9.5 | ≈-9.5 | · | · | |
| Price / Cash Flow (TTM) | 42.65Y avg ≈-39.0 | ≈-39.0 | · | · | |
| EV / Revenue (TTM) | 4.65Y avg ≈13.3 | ≈13.3 | · | · | |
| EV / FCF (TTM) | 49.75Y avg ≈-42.8 | ≈-42.8 | · | · | |
| Price / Tangible Book (MRQ) | 9.35Y avg ≈5.7 | ≈5.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | TARS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -8.0%5Y avg ≈-233.3% | ≈-233.3% | 2.4% | Weak | |
| EBITDA Margin | -15.7%5Y avg ≈-233.3% | ≈-233.3% | 2.6% | Weak | |
| Pretax Margin | -14.3%5Y avg ≈-224.2% | ≈-224.2% | 10.3% | Weak | |
| Net Profit Margin (TTM) | -7.7%5Y avg ≈-224.3% | ≈-224.3% | 7.1% | Weak | |
| ROA (TTM) | -8.4%5Y avg ≈-28.7% | ≈-28.7% | -7.0% | Weak | |
| ROE (TTM) | -13.7%5Y avg ≈-35.0% | ≈-35.0% | -20.8% | In line | |
| ROIC | -17.6%5Y avg ≈-31.7% | ≈-31.7% | -11.7% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | TARS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.25Y avg ≈0.2 | ≈0.2 | 1.4 | Low debt | |
| Current Ratio (MRQ) | 3.25Y avg ≈9.0 | ≈9.0 | 2.7 | Strong liquidity | |
| Quick Ratio (MRQ) | 3.15Y avg ≈8.7 | ≈8.7 | 1.8 | Strong liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.25Y avg ≈0.2 | ≈0.2 | 1.4 | Low debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | TARS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 146.7%5Y avg ≈252.0% | ≈252.0% | · | · | |
| Revenue CAGR 3Y | 159.5% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | TARS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.05Y avg ≈0.4 | ≈0.4 | 0.8 | Top tier | |
| Receivables Turnover | 6.85Y avg ≈4.9 | ≈4.9 | 4.6 | Top tier | |
| Revenue / Employee | ≈$1.2M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-25.2%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 4, 2026 | $-0.43 | $-0.20 | -115.1% |
| March 31, 2026 | May 12, 2026 | $-0.16 | $-0.38 | 57.6% |
| Dec. 31, 2025 | $-0.20 | $-0.10 | -106.2% | |
| Sept. 30, 2025 | $-0.30 | $-0.36 | 16.1% | |
| June 30, 2025 | $-0.48 | $-0.41 | -17.8% | |
| March 31, 2025 | $-0.64 | $-0.75 | 14.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $451M | $183M | $17M | $26M | $57M | $0 | |
| R&D Expense | $64M | $53M | $50M | $43M | $42M | $19M | |
| SG&A Expense | $427M | $237M | $109M | $45M | $25M | $8M | |
| Operating Expenses | $522M | $304M | $161M | $89M | $69M | $27M | |
| Operating Income | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M | |
| Interest Expense | · | · | $3M | $2M | $0 | · | |
| Other Non-op | $-202.0K | $-206.0K | $274.0K | $86.0K | $-73.0K | $0 | |
| Pretax Income | $-64M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Income Tax | $2M | $0 | $0 | $-4.0K | $55.0K | $1.0K | |
| Net Income | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| EPS (Basic) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| EPS (Diluted) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| Shares (Basic) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| Shares (Diluted) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| EBITDA | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $184M | $95M | $225M | $72M | $171M | $168M | |
| Short-term Investments | $234M | $197M | $2M | $145M | $483.0K | $0 | |
| Receivables | $85M | $47M | $17M | $0 | $0 | $0 | |
| Inventory | $4M | $3M | $3M | $0 | · | · | |
| Prepaid Expense | $13M | $15M | $8M | $5M | $4M | $2M | |
| Current Assets | $523M | $357M | $256M | $225M | $176M | $171M | |
| PP&E (Net) | $12M | $2M | $1M | $957.0K | $755.0K | $548.0K | |
| PP&E (Gross) | $14M | $4M | $3M | $2M | $976.0K | $682.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $546.0K | $221.0K | $134.0K | |
| Intangibles | $7M | $8M | $4M | $0 | · | · | |
| Other Non-current Assets | $2M | $999.0K | $2M | $585.0K | $1M | $81.0K | |
| Total Assets | $562M | $377M | $265M | $228M | $179M | $172M | |
| Accounts Payable | $16M | $9M | · | · | · | · | |
| Current Liabilities | $136M | $81M | $37M | $15M | $11M | $5M | |
| Capital Leases | $11M | $0 | $2M | $52.0K | $585.0K | $549.0K | |
| Other Non-current Liabilities | $11M | $0 | $2M | $100.0K | $699.0K | $605.0K | |
| Total Liabilities | $219M | $152M | $69M | $35M | $12M | $6M | |
| Long-term Debt | $72M | $72M | $30M | $19M | · | · | |
| Total Debt | $72M | $72M | $30M | $19M | · | · | |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | |
| Paid-in Capital | $770M | $585M | $442M | $302M | $213M | $199M | |
| Retained Earnings | $-427M | $-360M | $-245M | $-109M | $-47M | $-33M | |
| AOCI | $381.0K | $179.0K | $-2.0K | $-74.0K | $0 | · | |
| Stockholders' Equity | $343M | $225M | $197M | $193M | $167M | $166M | |
| Liabilities + Equity | $562M | $377M | $265M | $228M | $179M | $172M | |
| Shares Outstanding | 42,553,931 | 38,349,826 | 34,211,190 | 26,727,458 | 20,698,737 | 20,323,201 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $42M | $28M | $20M | $13M | $8M | $839.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $961.0K | $540.0K | $133.0K | $0 | · | · | |
| Operating Cash Flow | $-12M | $-83M | $-117M | $-49M | $4M | $-21M | |
| CapEx | $10M | $2M | $2M | $506.0K | $586.0K | $456.0K | |
| Investing Cash Flow | $-42M | $-199M | $141M | $-145M | $-586.0K | $-456.0K | |
| Debt Issued | $0 | $75M | $10M | $20M | · | · | |
| Net Debt Issued | $0 | $75M | · | · | · | · | |
| Financing Cash Flow | $143M | $155M | $130M | $94M | $21.0K | $132M | |
| Net Change in Cash | $89M | $-128M | $153M | $-100M | $3M | $110M | |
| Free Cash Flow | $-22M | $-85M | $-119M | $-50M | $3M | $-22M | |
| Levered FCF | · | · | $-122M | $-52M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| Net Margin | -14.7% | -63.2% | -778.9% | -240.5% | -24.2% | · | |
| Pretax Margin | -14.3% | -63.2% | -778.9% | -240.5% | -24.1% | · | |
| EBITDA Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| ROA | -14.1% | -36.0% | -55.1% | -30.5% | -7.9% | -23.3% | |
| ROE | -19.7% | -50.0% | -66.2% | -31.4% | -8.0% | -36.2% | |
| ROIC | -17.6% | -40.7% | -63.1% | -29.5% | -7.3% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 | 31.7 | |
| Quick Ratio | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 | 31.2 | |
| Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | -42.8 | -28.5 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.1 | 0.1 | 0.3 | · | |
| Receivables Turnover | 6.8 | 5.8 | 2.1 | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.07 | $5.85 | $5.76 | $7.22 | $8.06 | $8.17 | |
| Revenue / Share | $10.80 | $4.87 | $0.59 | $1.05 | $2.77 | · | |
| Cash Flow / Share | $-0.30 | $-2.21 | $-4.00 | $-1.99 | $0.18 | · | |
| Cash / Share | $4.32 | $2.47 | $6.58 | $2.68 | $8.28 | $8.27 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | 948.6% | -32.4% | -54.7% | · | · | |
| Revenue CAGR 3Y | 159.5% | 47.5% | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $451M | $183M | $17M | $26M | $57M | $0 | |
| Net Income TTM | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Market Cap | $3.48B | $2.12B | $693M | $392M | $466M | $840M | |
| Enterprise Value | $3.14B | $1.90B | $495M | $194M | · | · | |
| P/E | -51.5 | -18.0 | -4.4 | -5.8 | -33.6 | -9.6 | |
| P/S | 7.7 | 11.6 | 39.7 | 15.2 | 8.2 | · | |
| P/B | 10.1 | 9.5 | 3.5 | 2.0 | 2.8 | 5.1 | |
| P / Tangible Book | 10.4 | 9.8 | 3.6 | 2.0 | 2.8 | 5.1 | |
| P / Cash Flow | -279.8 | -25.6 | -5.9 | -8.0 | 124.3 | -39.7 | |
| P / FCF | -156.2 | -25.1 | -5.8 | -7.9 | 147.3 | -38.9 | |
| EV / EBITDA | -44.2 | -15.8 | -3.5 | -3.1 | · | · | |
| EV / FCF | -140.7 | -22.5 | -4.2 | -3.9 | · | · | |
| EV / Revenue | 7.0 | 10.4 | 28.4 | 7.5 | · | · | |
| Earnings Yield | -1.9% | -5.5% | -22.8% | -17.2% | -3.0% | -10.4% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $174M | $162M | $152M | $119M | $103M | $78M | $66M | $48M | $41M | $28M | $13M | $2M | $0 | $2M | $10M | $0 | |
| Cost of Revenue | $12M | $9M | · | · | $6M | $5M | · | · | · | · | · | · | $0 | $0 | · | $0 | |
| R&D Expense | $31M | $22M | $18M | $16M | $16M | $14M | $17M | $12M | $12M | $12M | $13M | $12M | $13M | $12M | $10M | $11M | |
| SG&A Expense | $151M | $136M | $131M | $109M | $103M | $85M | $69M | $58M | $59M | $52M | $43M | $30M | $20M | $15M | $15M | $12M | |
| Operating Expenses | $194M | $168M | $160M | $133M | $125M | $105M | $91M | $73M | $74M | $65M | $58M | $43M | $33M | $27M | $25M | $23M | |
| Operating Income | $-20M | $-6M | $-8M | $-15M | $-22M | $-26M | $-24M | $-25M | $-33M | $-38M | $-44M | $-41M | $-33M | $-25M | $-15M | $-23M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $983.0K | · | $858.0K | $815.0K | $684.0K | · | $633.0K | |
| Other Non-op | $-281.0K | $-87.0K | $-74.0K | $98.0K | $-145.0K | $-81.0K | $-27.0K | $67.0K | $-65.0K | $-181.0K | $363.0K | $-48.0K | $-47.0K | $6.0K | $-50.0K | $-7.0K | |
| Income Tax | $3M | $2M | · | · | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-5.0K | |
| Net Income | $-19M | $-7M | $-8M | $-13M | $-20M | $-25M | $-23M | $-23M | $-33M | $-36M | $-42M | $-39M | $-31M | $-23M | $-14M | $-23M | |
| EPS (Basic) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| EPS (Diluted) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| Shares (Basic) | 43,393,643 | 42,956,973 | · | 42,607,717 | 42,360,452 | 39,345,359 | · | 38,381,968 | 37,823,233 | 35,300,655 | · | 30,622,440 | 26,815,733 | 26,742,023 | · | 26,662,374 | |
| Shares (Diluted) | 43,393,643 | 42,956,973 | · | 42,607,717 | 42,360,452 | 39,345,359 | · | 38,381,968 | 37,823,233 | 35,300,655 | · | 30,622,440 | 26,815,733 | 26,742,023 | · | 26,662,374 | |
| EBITDA | $-20M | $-6M | · | $-15M | $-22M | $-26M | · | $-25M | $-33M | $-38M | · | $-41M | $-33M | $-25M | · | $-23M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $102M | $184M | $113M | $97M | $176M | $95M | $176M | $181M | $194M | · | $227M | $107M | $66M | · | $169M | |
| Short-term Investments | $245M | $287M | $234M | $289M | $284M | $232M | $197M | $141M | $142M | $105M | · | $20M | $71M | $135M | · | $57M | |
| Receivables | $96M | $100M | $85M | $73M | $58M | $62M | $47M | $29M | $30M | $30M | · | $5M | · | $2M | · | $17.0K | |
| Inventory | $4M | $5M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $4M | · | $15.0K | · | · | · | · | |
| Prepaid Expense | $10M | $27M | $13M | $22M | $29M | $6M | $15M | $7M | $6M | $7M | · | $6M | $5M | $5M | · | $3M | |
| Current Assets | $562M | $537M | $523M | $502M | $474M | $481M | $357M | $357M | $363M | $341M | · | $259M | $183M | $209M | · | $234M | |
| PP&E (Net) | $20M | $18M | $12M | $6M | $3M | $3M | $2M | $2M | $2M | $1M | · | $2M | $2M | $1M | · | $951.0K | |
| PP&E (Gross) | $22M | $20M | $14M | $8M | $6M | $5M | $4M | $4M | $4M | $3M | · | $3M | $2M | $2M | · | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $832.0K | $649.0K | · | $448.0K | |
| Intangibles | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $4M | $4M | · | $4M | · | · | · | · | |
| Other Non-current Assets | $660.0K | $715.0K | $2M | $1M | $1M | $616.0K | $999.0K | $888.0K | $846.0K | $1M | · | $1M | $1M | $529.0K | · | $583.0K | |
| Total Assets | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Accounts Payable | $40M | $24M | $16M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $176M | $144M | $136M | $117M | $90M | $86M | $81M | $66M | $52M | $43M | · | $23M | $15M | $13M | · | $14M | |
| Capital Leases | $16M | $16M | $11M | $10M | $0 | $0 | · | $1M | $1M | $2M | · | $2M | $2M | · | · | $169.0K | |
| Other Non-current Liabilities | $16M | $16M | $11M | $10M | · | · | $0 | $1M | $1M | $2M | · | $2M | $2M | $40.0K | · | $209.0K | |
| Total Liabilities | $264M | $232M | $219M | $199M | $162M | $158M | $152M | $139M | $125M | $74M | · | $55M | $41M | $38M | · | $34M | |
| Long-term Debt | $73M | $73M | $72M | $72M | $72M | $72M | $72M | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Total Debt | $73M | $73M | · | $72M | $72M | $72M | · | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Paid-in Capital | $799M | $783M | $770M | $753M | $738M | $728M | $585M | $574M | $566M | $556M | · | $416M | $311M | $306M | · | $298M | |
| Retained Earnings | $-452M | $-434M | $-427M | $-418M | $-406M | $-385M | $-360M | $-337M | $-314M | $-280M | · | $-203M | $-164M | $-132M | · | $-95M | |
| AOCI | $-557.0K | $-298.0K | $381.0K | $289.0K | $39.0K | $85.0K | $179.0K | $346.0K | $-176.0K | $-63.0K | · | $-8.0K | $-23.0K | $-70.0K | · | $-10.0K | |
| Stockholders' Equity | $347M | $349M | $343M | $335M | $333M | $342M | $225M | $237M | $252M | $275M | $197M | $214M | $148M | $173M | $193M | $203M | |
| Liabilities + Equity | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Shares Outstanding | 43,271,347 | 43,021,312 | 42,553,931 | 42,447,882 | 42,210,972 | 41,995,537 | 38,349,826 | 38,196,072 | 38,030,385 | 37,749,468 | 34,211,190 | 33,104,087 | 26,899,572 | 26,800,512 | 26,727,458 | 26,671,812 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $12M | $14M | $12M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Amort. of Intangibles | $200.0K | $240.0K | $321.0K | $200.0K | $200.0K | $240.0K | $240.0K | $100.0K | $100.0K | $100.0K | $133.0K | $0 | $0 | $0 | $0 | · | |
| Operating Cash Flow | $61M | $-25M | $19M | $18M | $-29M | $-21M | $-22M | $-9M | $-14M | $-38M | $-39M | $-32M | $-24M | $-22M | $-11M | $-19M | |
| CapEx | $4M | $6M | $6M | $2M | $1M | $590.0K | $72.0K | $282.0K | $1M | $174.0K | $0 | $375.0K | $787.0K | $340.0K | $127.0K | $96.0K | |
| Investing Cash Flow | $38M | $-59M | $49M | $-5M | $-52M | $-35M | $-60M | $3M | $-41M | $-102M | $18M | $47M | $64M | $11M | $-87M | $-57M | |
| Debt Issued | · | · | $0 | $0 | · | · | $0 | $0 | $75M | $0 | $0 | $5M | $0 | $5M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $5M | · | · | |
| Stock Issued | $0 | $0 | · | $0 | $-354.0K | $135M | · | $-43.0K | $-274.0K | $99M | · | $99M | $0 | $0 | · | $-218.0K | |
| Net Stock Activity | · | $0 | · | · | · | $135M | · | · | · | $99M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $1M | $2M | $3M | $2M | $137M | $3M | $639.0K | $42M | $109M | $20M | $105M | $510.0K | $5M | $264.0K | $-136.0K | |
| Net Change in Cash | $102M | $-82M | $71M | $16M | $-79M | $81M | $-79M | $-5M | $-13M | $-31M | $-2M | $120M | $41M | $-6M | $-98M | $-76M | |
| Taxes Paid | $3M | $2M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-30M | · | · | · | $-21M | · | · | · | $-38M | · | · | · | $-22M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| Net Margin | -10.7% | -4.3% | · | -10.6% | -19.8% | -32.1% | · | -48.7% | -81.6% | -129.4% | · | -2092.4% | · | · | · | · | |
| EBITDA Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| ROA | -3.4% | -1.3% | · | -2.8% | -4.7% | -5.9% | · | -7.3% | -11.8% | -12.8% | · | -15.5% | -14.2% | -11.9% | · | -10.5% | |
| ROE | -5.5% | -2.0% | · | -4.4% | -7.0% | -8.1% | · | -10.4% | -16.7% | -15.9% | · | -18.8% | -17.0% | -14.5% | · | -11.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | · | 4.3 | 5.3 | 5.6 | · | 5.4 | 7.0 | 8.0 | · | 11.2 | 12.4 | 15.7 | · | 16.4 | |
| Quick Ratio | 3.1 | 3.4 | · | 4.1 | 4.9 | 5.4 | · | 5.3 | 6.8 | 7.7 | · | 10.8 | 12.1 | 15.4 | · | 15.9 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -38.3 | · | -47.7 | -40.3 | -36.5 | · | -36.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | · | · | · | 0.0 | |
| Inventory Turnover | 2.9 | 2.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 2.3 | 2.0 | · | 2.3 | 2.3 | 1.7 | · | 2.8 | 2.8 | 1.7 | · | 0.7 | · | · | · | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.01 | $8.11 | · | $7.89 | $7.88 | $8.15 | · | $6.22 | $6.63 | $7.29 | · | $6.45 | $5.49 | $6.47 | · | $7.60 | |
| Revenue / Share | $4.01 | $3.77 | · | $2.79 | $2.42 | $1.99 | · | $1.25 | $1.08 | $0.78 | · | $0.06 | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.57 | · | · | · | $-0.52 | · | · | · | $-1.07 | · | · | · | $-0.82 | · | · | |
| Cash / Share | $4.73 | $2.38 | · | $2.66 | $2.29 | $4.19 | · | $4.61 | $4.76 | $5.13 | · | $6.85 | $3.97 | $2.46 | · | $6.35 | |
| EPS (TTM) | $-1.06 | $-1.11 | · | $-1.99 | $-2.30 | $-2.70 | · | $-3.79 | $-4.46 | $-4.75 | · | $-3.79 | $-3.35 | $-2.42 | · | $-2.73 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606M | $535M | · | $366M | $296M | $234M | · | $130M | $83M | $43M | · | $14M | $12M | $28M | · | $16M | |
| Net Income TTM | $-46M | $-48M | · | $-81M | $-92M | $-105M | · | $-134M | $-150M | $-148M | · | $-108M | $-91M | $-65M | · | $-63M | |
| Market Cap | $2.72B | $3.02B | · | $2.52B | $1.71B | $2.16B | · | $1.26B | $1.03B | $1.37B | · | $588M | $486M | $337M | · | $457M | |
| Enterprise Value | $2.35B | $2.70B | · | $2.19B | $1.40B | $1.82B | · | $1.01B | $782M | $1.10B | · | $371M | $332M | $160M | · | $249M | |
| P/E | -59.4 | -63.2 | · | -29.9 | -17.6 | -19.0 | · | -8.7 | -6.1 | -7.7 | · | -4.7 | -5.4 | -5.2 | · | -6.3 | |
| P/S | 4.5 | 5.6 | · | 6.9 | 5.8 | 9.2 | · | 9.7 | 12.4 | 32.2 | · | 40.9 | 38.9 | 12.1 | · | 28.3 | |
| P/B | 7.9 | 8.6 | · | 7.5 | 5.1 | 6.3 | · | 5.3 | 4.1 | 5.0 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Tangible Book | 8.0 | 8.8 | · | 7.7 | 5.3 | 6.5 | · | 5.5 | 4.2 | 5.1 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Cash Flow | · | -122.4 | · | · | · | -104.5 | · | · | · | -36.3 | · | · | · | -15.3 | · | · | |
| EV / Revenue | 3.9 | 5.0 | · | 6.0 | 4.7 | 7.8 | · | 7.8 | 9.4 | 25.9 | · | 25.8 | 26.6 | 5.8 | · | 15.4 | |
| Earnings Yield | -1.7% | -1.6% | · | -3.4% | -5.7% | -5.3% | · | -11.5% | -16.4% | -13.1% | · | -21.3% | -18.5% | -19.2% | · | -16.0% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $451M | $183M | $17M | $26M | $57M |
| Operating Margin % | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% |
| Net Income | $-66M | $-116M | $-136M | $-62M | $-14M |
| Diluted EPS | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · |
| Current Ratio | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 |
| Quick Ratio | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-22M | $-85M | $-119M | $-50M | $3M |
Institutional owners (13F) 276 filers · $3.2B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
276
Value held
$3.2B
New positions
37
Exited positions
33
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 37 (-20 vs prior Q) | 33 (+2 vs prior Q) | 104 (+14 vs prior Q) | 85 (+9 vs prior Q) | -286K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $242,705,264 | 3,856,137 | 7.67% | Shares |
| Deep Track Capital, LP | $230,786,378 | 3,666,768 | 7.30% | Shares |
| RTW INVESTMENTS, LP | $211,293,293 | 3,357,059 | 6.68% | Shares |
| VANGUARD GROUP INC | $196,475,972 | 2,399,560 | 6.21% | Shares |
| Paradigm Biocapital Advisors LP | $174,699,348 | 2,775,649 | 5.52% | Shares |
| JANUS HENDERSON GROUP PLC | $157,222,823 | 2,240,963 | 4.97% | Shares |
| MORGAN STANLEY | $114,996,594 | 1,827,082 | 3.64% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $112,855,448 | 1,793,064 | 3.57% | Shares |
| JENNISON ASSOCIATES LLC | $104,710,448 | 1,663,655 | 3.31% | Shares |
| TANG CAPITAL MANAGEMENT LLC | $98,706,662 | 1,568,266 | 3.12% | Shares |
| MILLENNIUM MANAGEMENT LLC | $89,823,185 | 1,427,124 | 2.84% | Shares |
| BANK OF AMERICA CORP /DE/ | $75,098,874 | 1,193,182 | 2.37% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $69,605,544 | 1,105,689 | 2.20% | Shares |
| STATE STREET CORP | $67,531,536 | 1,072,951 | 2.13% | Shares |
| Vestal Point Capital, LP | $66,087,000 | 1,050,000 | 2.09% | Shares |
| Assenagon Asset Management S.A. | $59,635,335 | 947,495 | 1.89% | Shares |
| Invesco Ltd. | $49,458,755 | 785,808 | 1.56% | Shares |
| GOLDMAN SACHS GROUP INC | $46,745,097 | 742,693 | 1.48% | Shares |
| Frazier Life Sciences Management, L.P. | $45,860,853 | 728,644 | 1.45% | Shares |
| D. E. Shaw & Co., Inc. | $44,722,583 | 710,559 | 1.41% | Shares |
| FMR LLC | $42,355,422 | 672,949 | 1.34% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $38,222,000 | 607,272 | 1.21% | Shares |
| Clearbridge Investments, LLC | $34,578,420 | 549,387 | 1.09% | Shares |
| TORONTO DOMINION BANK | $32,115,324 | 510,253 | 1.02% | Shares |
| TimesSquare Capital Management, LLC | $27,259,589 | 388,590 | 0.86% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $26,875,883 | 427,008 | 0.85% | Shares |
| Caption Management, LLC | $25,805,400 | 410,000 | 0.82% | Put option |
| NORTHERN TRUST CORP | $24,333,296 | 386,611 | 0.77% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $24,240,523 | 385,137 | 0.77% | Shares |
| LOOMIS SAYLES & CO L P | $23,960,251 | 380,684 | 0.76% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $21,137,392 | 335,834 | 0.67% | Shares |
| Tri Locum Partners LP | $20,665,720 | 328,340 | 0.65% | Shares |
| MPM BIOIMPACT LLC | $20,267,121 | 322,007 | 0.64% | Shares |
| Driehaus Capital Management LLC | $19,988,233 | 317,576 | 0.63% | Shares |
| Squarepoint Ops LLC | $18,619,163 | 295,824 | 0.59% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $18,019,030 | 286,289 | 0.57% | Shares |
| FRANKLIN RESOURCES INC | $18,001,343 | 286,008 | 0.57% | Shares |
| Artisan Partners Limited Partnership | $17,931,543 | 284,899 | 0.57% | Shares |
| Rock Springs Capital Management LP | $17,439,856 | 277,087 | 0.55% | Shares |
| Ensign Peak Advisors, Inc | $16,911,726 | 268,696 | 0.53% | Shares |
| CITADEL ADVISORS LLC | $15,214,927 | 241,737 | 0.48% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $12,690,215 | 201,624 | 0.40% | Shares |
| MACKENZIE FINANCIAL CORP | $12,048,478 | 191,428 | 0.38% | Shares |
| JANE STREET GROUP, LLC | $11,964,894 | 190,100 | 0.38% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11,864,190 | 188,500 | 0.38% | Call option |
| Cutter Capital Management, LP | $10,530,850 | 205,000 | 0.33% | Shares |
| Parkman Healthcare Partners LLC | $9,441,000 | 150,000 | 0.30% | Shares |
| JPMORGAN CHASE & CO | $8,683,850 | 139,981 | 0.27% | Shares |
| Allspring Global Investments Holdings, LLC | $7,935,733 | 130,329 | 0.25% | Shares |
| Seven Fleet Capital Management LP | $7,909,873 | 117,067 | 0.25% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Horowitz Limited Partnership VIII, Horowitz Management, Inc., Adam S. Horowitz Revocable Trust, Jason E. Tester | Oct. 30, 2020 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 21 insiders · 10 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Bobak R. Azamian | President/CEO and Board Chair | Sept. 4, 2026 S | 827,991 | 0 | 10 | $-5,181,683 |
| Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | June 15, 2026 M | 56,801 | 0 | 4 | $-1,317,002 |
| Leonard M. Greenstein | Chief Financial Officer | April 20, 2023 S | 26,785 | 0 | 0 | $0 |
| Seshadri Neervannan | Chief Operating Officer | Sept. 4, 2026 S | 78,532 | 0 | 6 | $-2,001,321 |
| Elizabeth Yeu Lin | Chief Medical Officer | Sept. 4, 2026 S | 1,590 | 0 | 11 | $-2,362,279 |
| Bryan Wahl | General Counsel | March 19, 2026 S | 63,959 | 0 | 3 | $-850,417 |
| Dianne C. Whitfield | Chief Human Resources Officer | March 19, 2026 S | 35,028 | 0 | 8 | $-2,687,252 |
| Aziz Mottiwala | Chief Commercial Officer | March 19, 2026 S | 61,480 | 0 | 3 | $-892,528 |
| Jose M. Trevejo | CHIEF MEDICAL OFFICER | Dec. 20, 2023 S | 2,251 | 0 | 0 | $0 |
| Mark J. Holdbrook | V.P., Clinical Affairs | March 20, 2023 S | 3,191 | 0 | 0 | $0 |
| William J Link PHD | Director | Sept. 15, 2026 M | 94,487 | 0 | 13 | $-4,480,738 |
| Wendy L Yarno | Director | Sept. 15, 2026 M | 16,956 | 0 | 0 | $0 |
| David E I Pyott | Director | Sept. 15, 2026 M | 9,575 | 0 | 0 | $0 |
| Katherine Goodrich | Director | June 25, 2026 A | 2,233 | 0 | 1 | $-183,384 |
| Andrew D. Goldberg | Director | June 25, 2026 A | 19,654 | 0 | 0 | $0 |
| Scott W Morrison | Director | June 25, 2026 A | 7,638 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Director | June 25, 2026 A | 11,654 | 0 | 0 | $0 |
| Rosemary A Crane | Director | June 24, 2024 M | 5,350 | 0 | 0 | $0 |
| Michael Ackermann | Director | June 16, 2022 A | 1,208,273 | 0 | 0 | $0 |
| Jason E. Tester | Director | June 15, 2021 A | 1,920,933 | 0 | 0 | $0 |
| Horowitz Limited Partnership VIII | 10% owner | Oct. 20, 2020 C | 66,172 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 36 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 3.53% | 250,245 SH | Oct. 1, 2026 | Daily |
| BBP · ETFis Series Trust I | 1.31% | 21,906 NS | July 31, 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.10% | 3,832 NS | July 31, 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1.03% | 29,628 NS | July 31, 2026 | N-PORT |
| IHE · iShares Trust | 0.73% | 146,508 SH | Sept. 11, 2026 | Daily |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.25% | 55,774 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.24% | 308,150 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.24% | 3,264 SH | Oct. 1, 2026 | Daily |
| IWO · iShares Trust | 0.22% | 392,987 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.16% | 44,912 SH | Aug. 19, 2026 | Daily |
| ESSC · Strategy Shares | 0.16% | 952 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.11% | 1,070,015 SH | Sept. 11, 2026 | Daily |
| ISCG · iShares Trust | 0.10% | 12,082 SH | Sept. 11, 2026 | Daily |
| FSMD · FIDELITY COVINGTON TRUST | 0.10% | 42,141 NS | July 31, 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.09% | 1,364 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.09% | 10,366 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.08% | 241,028 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.08% | 20,052 NS | July 31, 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.06% | 13,860 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.06% | 19,942 SH | Sept. 11, 2026 | Daily |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.05% | 5,052 NS | July 31, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.05% | 1,556 SH | Oct. 1, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 455,389 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.03% | 89,651 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 9,191 SH | Oct. 1, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 14,156 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.02% | 1,911 SH | Sept. 11, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.02% | 6,187 SH | Aug. 19, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 54,976 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 1,580 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 9,991 SH | Sept. 11, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,295,901 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,359 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 1,731 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 66,526 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 1,979 SH | Sept. 1, 2026 | Daily |
TARS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 14 analysts
BUY
Median target
$100.00
+37.0%
7 50.0%
Strong Buy
6 42.9%
Buy
1 7.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-09-30Mean target $99.50 +36.3%
← Below all targets
Current price $73.00
Low$84.00
Mean$99.50
High$116.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | · |
| INDV | · | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| AMLX | $1.33B | -7.9 | -77.1% | · | -61.2% | · |
| ELVN | $915M | -8.4 | · | · | -21.9% | · |
| MBX | $1.42B | -13.3 | · | · | -29.6% | · |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | · |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026